T1D Stem Cell Success Story; Lilly’s Discount Tirzepatide Vials; Stelo Now Available

A type 1 diabetes patient talked about her successful treatment with an investigational stem cell therapy currently in trials, noting that she hasn’t needed insulin since last August. (Washington Post)

Eli Lilly said tirzepatide (Zepbound) single-dose vials are available for self-pay through LillyDirect, significantly expanding the supply for patients with obesity.

Risk for dementia was similar for Korean adults 60 and older with type 2 diabetes whether they were on SGLT2 inhibitors versus the GLP-1 receptor agonist dulaglutide (Trulicity), a population-based cohort study suggested. (Annals of Internal Medicine)

The Menopause Society announced the launch of its new monthly series, Menopause Step-by-Step, which will address key issues about managing menopause.

Epic Research data indicated that older adults with diabetes diagnosed with Alzheimer’s disease were more likely to have average HbA1c values under 6.5% or over 8% in the 5 years prior to the diagnosis compared with diabetic patients without Alzheimer’s.

Wall Street thinks semaglutide (Ozempic, Wegovy) may become a target of Medicare drug price negotiations in 2027. (Reuters)

One in seven Medicare beneficiaries are likely to newly qualify for semaglutide based on the drug’s cardiovascular disease indication, researchers estimated. (Annals of Internal Medicine)

Stelo, the first over-the-counter glucose biosensor, is now available for adults not using insulin, said maker Dexcom.

Ahead of a Senate committee hearing next month, Novo Nordisk’s CEO defended the price of the company’s blockbuster drug semaglutide, which ranges from $92 in the U.K. to $1,300 in the U.S. for a monthly supply of the weight-loss formulation. (NBC News)

Seven out of 25 treatment-naive patients with acromegaly had paradoxically increased growth hormone secretion during the diagnostic oral glucose tolerance test, but a GIP receptor antagonist infusion eliminated this response in four patients. (Journal of Clinical Endocrinology & Metabolism)

The Endocrine Society announced 14 leading endocrinologists as the winners of its 2025 Laureate Awards, the top honors in the field.

The FDA turned down an appeal by Intarcia to reverse its rejection of the company’s implant that delivers a GLP-1 agonist for type 2 diabetes, a product that agency advisors unanimously voted against last September. (Endpoints News)

A meta-analysis found that red meat consumption was tied to an increased incidence of type 2 diabetes. (Lancet Diabetes & Endocrinology)

A researcher at Mount Sinai Health System received a $4 million NIH grant to study the role of the mammary gland secretome in metabolic health.

Does HPV in men affect fertility? (Frontiers in Cellular and Infection Microbiology)

Please enable JavaScript to view the comments powered by Disqus.